<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Dagres, N</style></author><author><style face="normal" font="default" size="100%">Karatasakis, G</style></author><author><style face="normal" font="default" size="100%">Panou, F</style></author><author><style face="normal" font="default" size="100%">Athanassopoulos, G</style></author><author><style face="normal" font="default" size="100%">Maounis, T</style></author><author><style face="normal" font="default" size="100%">Tsougos, E</style></author><author><style face="normal" font="default" size="100%">Kourea, K</style></author><author><style face="normal" font="default" size="100%">Malakos, I</style></author><author><style face="normal" font="default" size="100%">Kremastinos, D.T.</style></author><author><style face="normal" font="default" size="100%">Cokkinos, D.V.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Arrhythmia/electrophysiology Pre-treatment with lrbesartan attenuates left atrial stunning after electrical cardioversion of atrial fibrillation</style></title><secondary-title><style face="normal" font="default" size="100%">EUROPEAN HEART JOURNAL</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2006</style></year></dates><number><style face="normal" font="default" size="100%">17</style></number><publisher><style face="normal" font="default" size="100%">Oxford University Press</style></publisher><volume><style face="normal" font="default" size="100%">27</style></volume><pages><style face="normal" font="default" size="100%">2062–2067</style></pages><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>